Vikhyat Bebarta, MD

M.D., 1998, George Washington University School of Medicine and Health Sciences


Kian Behbakht

Associate Professor
M.D., 1989, Ohio State University College of Medicine

Innovative new treatments for ovarian cancers. 

Timothy Benke


M.D. 1995, Baylor College of Medicine, PhD 1994, Baylor College of Medicine, MS 1989 Rice University

Mechanisms of synaptic plasticity and impacts of development and epilepsy.


Fabrice Dabertrand

Assistant Professor
Ph.D., 2006, University of Bordeaux, France  

The overall goal of our laboratory is to understand the control of cerebral blood flow by ion channels and calcium signaling in the pericytes, endothelial cells, and smooth muscle cells that constitute the parenchymal microcirculation, and use this information to combat brain diseases with a vascular component.

Elan Eisenmesser, PhD

Associate Professor
Ph.D., Purdue University, 1998

The ultimate goal of the Eisenmesser lab is to fully characterize molecular interactions at both atomic resolution and biological levels with a particular emphasis on medically relevant systems that may be exploited to either block or promote events underlying disease progression.

Patricia Ernst

Ph.D., 1996, Uni. of California, Los Angeles

Hematopoietic Stem Cell Development and Maintenance: The Role of the "Mixed Lineage Leukemia" Gene in Normal Blood Cell Development, Differentiation and Leukemia.

Paco Herson

Associate Professor

Ph.D., 1999, Univ. of Aberdeen, UK

Basic translational research using neurophysiology, biochemistry, molecular biology, histology and neuro-behavior to elucidate the mechanisms of neuronal injury and identify therapeutic targets for protection and repair.


Vesna Jevtovic-Todorovic

Professor and Chair, Anesthesiology 

Mechanisms by which anesthetic drugs interact with neurotransmitter systems in the central nervous system to produce pharmacological and toxicological effects. 


Timothy McKinsey

Professor; Division of Cardiology
Division Head for Translational Research

Signaling and epigenetic mechanisms in cardiovascular disease. Drug discovery for cardiovascular diseases.

Mulcahy Levy_Jean

Jean Mulcahy Levy

Assistant Professor

MD, Oregon Health & Science University School of Medicine (2003) 

My clinical interests focus on the care of children with tumors involving the brain and spinal cord, using a combination of therapies and coordinating services including surgery, radiation, and chemotherapy to improve outcomes for these patients.


J. David Port

Ph.D., 1989, Univ. of Utah

G-protein linked receptors and their regulation; regulation of mRNA stability.

Pharmacology (SOM)

CU Anschutz

Research I North

12800 East 19th Avenue


Aurora, CO 80045


CMS Login